Skip to main content
Premium Trial:

Request an Annual Quote

Phthisis Diagnostics Reels In $549K in Grants

NEW YORK (GenomeWeb News) – Phthisis Diagnostics yesterday said that it has brought in $548,877 in grants from the Commonwealth of Virginia to support development and commercialization of its molecular diagnostic products.

The Charlottesville, Va.-based firm said that it received a $499,477 Commercialization Program grant and a Small Business Innovation Research Matching Fund award of $49,400 through the Commonwealth Research Commercialization Fund. Phthisis said it was one of only four companies in Virginia to receive a Commercialization Program grant.

"This funding will support development and launch of two molecular diagnostic kits that will fulfill a critical need for better diagnosis of intestinal parasites," Crystal Icenhour, president and chief science officer of Phthisis, said in a statement.

Phthisis was founded in 2005 and has developed a range of molecular diagnostic products under the Simply Molecular brand name. Its first product, the E-Sphere Stool DNA Extraction Kit, was launched this past May.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.